Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing
Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615